Stefani Wolff - Net Worth and Insider Trading
Stefani Wolff Net Worth
The estimated net worth of Stefani Wolff is at least $2 Million dollars as of 2024-11-05. Stefani Wolff is the Chief Development Officer of Principia Biopharma Inc and owns about 19,096 shares of Principia Biopharma Inc (PRNB) stock worth over $2 Million. Stefani Wolff is also the EVP and COO of Nurix Therapeutics Inc and owns about 6,113 shares of Nurix Therapeutics Inc (NRIX) stock worth over $148,363. Details can be seen in Stefani Wolff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stefani Wolff has not made any transactions after 2023-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stefani Wolff
Stefani Wolff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stefani Wolff owns 3 companies in total, including Principia Biopharma Inc (PRNB) , Nurix Therapeutics Inc (NRIX) , and Rain Oncology Inc (RAIN) .
Click here to see the complete history of Stefani Wolff’s form 4 insider trades.
Insider Ownership Summary of Stefani Wolff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-09-28 | Chief Development Officer |
| NRIX | Nurix Therapeutics Inc | 2023-05-01 | EVP and COO |
| RAIN | Rain Oncology Inc | 2021-04-22 | director |
Stefani Wolff Latest Holdings Summary
Stefani Wolff currently owns a total of 2 stocks. Among these stocks, Stefani Wolff owns 19,096 shares of Principia Biopharma Inc (PRNB) as of June 15, 2020, with a value of $2 Million and a weighting of 92.79%. Stefani Wolff also owns 6,113 shares of Nurix Therapeutics Inc (NRIX) as of May 1, 2023, with a value of $148,363 and a weighting of 7.21%.
Latest Holdings of Stefani Wolff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-06-15 | 19,096 | 100.05 | 1,910,555 |
| NRIX | Nurix Therapeutics Inc | 2023-05-01 | 6,113 | 24.27 | 148,363 |
Holding Weightings of Stefani Wolff
Stefani Wolff Form 4 Trading Tracker
According to the SEC Form 4 filings, Stefani Wolff has made a total of 5 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Principia Biopharma Inc is the sale of 5,504 shares on June 15, 2020, which brought Stefani Wolff around $334,368.
According to the SEC Form 4 filings, Stefani Wolff has made a total of 5 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 342 shares on May 1, 2023, which brought Stefani Wolff around $3,379.
Insider Trading History of Stefani Wolff
- 1
Stefani Wolff Trading Performance
Stefani Wolff Ownership Network
Ownership Network List of Stefani Wolff
Ownership Network Relation of Stefani Wolff
Stefani Wolff Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Stefani Wolff is the Chief Development Officer of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Scientific Officer David M Goldstein , and Chief Business Officer Roy C. Hardiman .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Stefani Wolff Mailing Address
Above is the net worth, insider trading, and ownership report for Stefani Wolff. You might contact Stefani Wolff via mailing address: C/o Principia Biopharma Inc., 400 East Jamie Court, Suite 302, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
